One.bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $12M

  • Investors
  • 9

One.bio General Information

Description

Developer of naturally-derived oligosaccharides designed for food, agriculture and biopharmaceutical applications. The company uses proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function, enabling clients to access novel prebiotics, symbiotic and immunomodulatory therapies for human and animal health.

Contact Information

Website
www.one.bio
Formerly Known As
Calyxo Biosystems, BCD Bioscience
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 231 G Street
  • Suite 24
  • Davis, CA 95616
  • United States
+1 (530) 000-0000

One.bio Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

One.bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A3) 13-Apr-2022 $12M 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A1) 09-Nov-2020 00.000 00.000 000.00 Completed Generating Revenue
1. Grant 29-Oct-2019 $316K Completed Startup
To view One.bio’s complete valuation and funding history, request access »

One.bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A3 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 6,544,863 $0.000100 6% $0.64 $0.64 1x $0.64 23.17%
To view One.bio’s complete cap table history, request access »

One.bio Patents

One.bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3214678-A1 Methods of use of oligosaccharide compositions for modulating microbiota and their metabolic products, and as therapeutics for health applications Pending 13-May-2021 00000000
EP-4337031-A1 Methods of use of oligosaccharide compositions for modulating microbiota and their metabolic products, and as therapeutics for health applications Pending 13-May-2021 00000000
US-20220372175-A1 High-yield peroxide quench-controlled polysaccharide depolymerization and compositions thereof Pending 14-Nov-2019 000000000
CA-3158746-A1 High-yield peroxide quench-controlled polysaccharide depolymerization and compositions thereof Pending 14-Nov-2019 000000000
EP-4057830-A1 High-yield peroxide quench-controlled polysaccharide depolymerization and compositions thereof Pending 14-Nov-2019 C08B30/20
To view One.bio’s complete patent history, request access »

One.bio Executive Team (7)

Name Title Board Seat Contact Info
Matt Barnard Co-Founder, Chief Executive Officer & Board Member
Matthew Amicucci Ph.D Co-Founder & Vice President, Research & Development
Steven Watkins Ph.D President
Carlito Lebrilla Ph.D Co-Founder & Board Member
Bruce German Ph.D Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

One.bio Board Members (5)

Name Representing Role Since
Carlito Lebrilla Ph.D Self Co-Founder & Board Member 000 0000
Danilo Massari Seventure Partners Board Member 000 0000
Gareth Asten Acre Venture Partners Board Member 000 0000
Matt Barnard One.bio Co-Founder, Chief Executive Officer & Board Member 000 0000
Oxana Kukhaneva Seventure Partners Board Member 000 0000
To view One.bio’s complete board members history, request access »

One.bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

One.bio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Collaborative Fund Venture Capital Minority 000 0000 000000 0
Skyviews Life Science Venture Capital Minority 000 0000 000000 0
SymBiosis Capital Management Venture Capital Minority 000 0000 000000 0
Acre Venture Partners Venture Capital Minority 000 0000 000000 0
Argonautic Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

One.bio FAQs

  • When was One.bio founded?

    One.bio was founded in 2019.

  • Who is the founder of One.bio?

    Matt Barnard, Matthew Amicucci Ph.D, Carlito Lebrilla Ph.D, Bruce German Ph.D, and David Mills Ph.D are the founders of One.bio.

  • Who is the CEO of One.bio?

    Matt Barnard is the CEO of One.bio.

  • Where is One.bio headquartered?

    One.bio is headquartered in Davis, CA.

  • What is the size of One.bio?

    One.bio has 31 total employees.

  • What industry is One.bio in?

    One.bio’s primary industry is Biotechnology.

  • Is One.bio a private or public company?

    One.bio is a Private company.

  • What is the current valuation of One.bio?

    The current valuation of One.bio is 0000.

  • What is One.bio’s current revenue?

    The current revenue for One.bio is 00000.

  • How much funding has One.bio raised over time?

    One.bio has raised $16.8M.

  • Who are One.bio’s investors?

    Collaborative Fund, Skyviews Life Science, SymBiosis Capital Management, Acre Venture Partners, and Argonautic Ventures are 5 of 9 investors who have invested in One.bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »